Arginine and ornithine are precursors of nitric oxide and polyamines, respectively. These metabolites intimately participate in permeability and adaptive responses of the gut. The liver possesses high arginase activity as an intrinsic part of urea synthesis and would consume most of the portal supply of dietary arginine. The gut reduces this possibility by converting dietary arginine to citrulline, which effectively bypass the liver and is resynthesised to arginine in the kidney. Dietary ornithine supplementation, in the form of ornithine a-ketoglutarate (OKG) can be considered as an arginine precursor. Several supplement studies have shown both amino acids to promote growth hormone and insulin secretion with anabolic effects in postoperative patients. Their intermediary metabolites (for example, glutamine, proline) may also be of benefit in trauma metabolism. Specific effects of either amino acid on the gut are poorly reported. One recent animal study showed improved morphology after OKG administration, perhaps through increased polyamine secretion. Generation of nitric oxide from arginine has two facets. Excess production from high dose arginine potentiated the effects of experimentally induced sepsis, whereas low doses improved survival. These considerations suggest that the role of enteral diet supplementation with arginine or OKG should be urgendy examined for any benefits it may have on mucosal barrier function.
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(Gut 1994; supplement 1: S42-S45) Metabolism of arginine and related compounds in the gut Arginine synthesis and catabolism in specific tissues is conditioned by the presence of arginosuccinase and arginase respectively, but only periportal hepatocytes and, to some extent, certain brain areas, possess all the enzymes required for arginine recycling and urea synthesis.' The gut acts as a user of arginine because it possesses arginase (isoenzyme II) and ornithine carbamoyltransferase.4
The gut thus releases urea and citrulline. 5 In addition, enterocytes express omithine decarboxylase6 and an NADPH2 dependent arginine deiminase78 which respectively lead to local production of aliphatic polyamines and nitric oxide.
Despite the high omithine decarboxylase activity in enterocytes, however, most of the omithine produced from arginine is released into the portal blood stream, and polyamine formation accounts for a small part of arginine consumption.8
After 14C-ornithine is given by the enteral route, 14C-proline, '4C-glutamate, and 14C-polyamines are detected,9 as expected, but, in contrast with arginine administration, no citrulline is produced. This could suggest a degree of metabolic compartmentalisation, arginine flux being directed preferentially towards ornithine and citrulline production. Indeed, omithine translocase, omithine carbamoyltransferase, and citrulline translocase function as a multienzyme complex' (Fig 1) . Figure 2 summarises arginine and omithine pathways in the gut.
Arginine and related compounds in artificial nutrition Arginine has multiple biological properties, including the ability to stimulate anabolic hormone secretion: intravenous and enteral arginine administration increases both insulin and human growth hormone secretion.'2 Several studies (reviewed in references 2 and 13) show that arginine given to patients as well as in various experimental stress models, acts by improving nitrogen balance, accelerating wound healing, and restoring depressed immunity (Table) . These effects are seen whether arginine is given orally'4 15 an additional propylamine moiety to spermidine, thus forming spermidine. The source of the propylamine groups is S-adenosyl methionine. 6 The functions of polyamines in mammalian cells are poorly understood, although the use of omithine decarboxylase inhibitors such as difluoromethyl omithine has established that polyamines are essential for cell growth6 and protein synthesis. 24 In this way, it has been clearly shown that the action of ornithine on fibroblast growth in culture25 and on protein synthesis by the liver26 are both dependent upon polyamine synthesis.
With regard to the intestine, there are consistent data supporting an important role of polyamines in the control of hypo and hyperplasia of this tissue. Ornithine decarboxylase in the mucosa of the small intestine has high basal activity compared with most tissues.6 Ornithine decarboxylase is associated with mature cells of the villus tip as well as proliferating crypt cells, suggesting that polyamines participate in both intestinal cell differentiation and proliferation. 27 Intestinal polyamine content falls after a fast28 and after an eight-day total parenteral nutrition programme in the rat,29 but increases during refeeding. 28 The fall in the concentrations of polyamines during fasting results from a simultaneous decrease in polyamine synthesis (that is, a decrease in ornithine decarboxylase content) and an increase in their degradation (that is, an increase in diamine oxydase content). The reverse is true during refeeding. 30 The trophic effect of nutrients seems to be due in particular to glucose and to amino acids such as glycine and alanine. 31 32 This effect is strong in the jejunum and ileum, moderate in the duodenum, and small in the proximal colon. 3 support a role for nitric oxide in the pathogenesis of septic shock syndrome. In this context, care must be taken with arginine supplementation in severely ill patients at risk of developing multiple organ failure. This dual effect of nitric oxide (and therefore arginine) is illustrated by a recent study from Alexander's group. 42 Septic guinea pigs supplemented with low doses of arginine recovered better than controls, whereas supplementation with high doses led to catastrophic results.
In conclusion, enterocytes contain high concentrations of polyamines, which play a crucial part in the control of cell multiplication and differentiation, and are able to synthesise nitric oxide, which emerges as a potent modulator of the response to inflammation. Despite these features, there is an extreme paucity of data on the action of arginine and omithine on gut function. Such studies are urgently required.
